Takeshi Nagashima
- Cancer Research top 1%
- Cancer Genomics and Diagnostics 32
- Breast Cancer Treatment Studies 29
- Immunology top 2%
- Molecular Biology top 2%
- Oncology top 2%
- Cancer Immunotherapy and Biomarkers 15
- HER2/EGFR in Cancer Research 14
- Biological Psychiatry top 5%
-
- Breast Lesions and Carcinomas 27
- Genetic factors in colorectal cancer 20
-
- Lung Cancer Treatments and Mutations 14
-
- MRI in cancer diagnosis 13
- Co-authors
- Ryo FunayamaKeiko NakayamaMasayuki YamamotoEri KobayashiTakafumi SuzukiMakiko HayashiHozumi MotohashiTakashi Moriguchi
- Partner nations
- JapanUnited StatesItaly
In The Last Decade
Takeshi Nagashima
195 papers receiving 6.1k citations
Hit Papers
Peers
Comparison fields: 5 of 150
- Cancer Research 1.3k
- Immunology 1.1k
- Molecular Biology 3.0k
- Oncology 1.2k
- Biological Psychiatry 96
Countries citing papers authored by Takeshi Nagashima
This map shows the geographic impact of Takeshi Nagashima's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Takeshi Nagashima with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Takeshi Nagashima more than expected).
Fields of papers citing papers by Takeshi Nagashima
This network shows the impact of papers produced by Takeshi Nagashima. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Takeshi Nagashima. The network helps show where Takeshi Nagashima may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Takeshi Nagashima, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2024 | 0 | |
| 2 | 2024 | 1 | |
| 3 | 2024 | 1 | |
| 4 | 2024 | 0 | |
| 5 | 2023 | 3 | |
| 6 | 2023 | 2 | |
| 7 | 2023 | 4 | |
| 8 | 2023 | 2 | |
| 9 | 2023 | 1 | |
| 10 | 2023 | 0 | |
| 11 | 2023 | 1 | |
| 12 | 2022 | 4 | |
| 13 | 2020 | 8 | |
| 14 | 2020 | 2 | |
| 15 | 2018 | 10 | |
| 16 | 2017 | 1 | |
| 17 | 2016 | 214 | |
| 18 | 2009 | 2 | |
| 19 | 2009 | 19 | |
| 20 | 2009 | 0 |
About Takeshi Nagashima
Takeshi Nagashima is a scholar working on Cancer Research, Oncology and Pathology and Forensic Medicine, having authored 208 papers that have together received 6.2k indexed citations. Recurring topics across this work include Cancer Genomics and Diagnostics (32 papers), Breast Cancer Treatment Studies (29 papers), Breast Lesions and Carcinomas (27 papers), Genetic factors in colorectal cancer (20 papers), Cancer Immunotherapy and Biomarkers (15 papers), HER2/EGFR in Cancer Research (14 papers), Lung Cancer Treatments and Mutations (14 papers) and MRI in cancer diagnosis (13 papers). The work is most often cited by research in Cancer Research (1.3k citations), Immunology (1.1k citations) and Molecular Biology (3.0k citations). Takeshi Nagashima has collaborated with scholars based in Japan, United States and Italy. Frequent co-authors include Ryo Funayama, Keiko Nakayama, Masayuki Yamamoto, Eri Kobayashi, Takafumi Suzuki, Makiko Hayashi, Hozumi Motohashi, Takashi Moriguchi, Nobuyuki Tanaka and Hiroki Sekine. Their work appears in journals such as Breast Cancer, Scientific Reports, Cancer Medicine, Cancer and Journal of Biological Chemistry.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.